A minimal model for hepatic fatty acid balance during fasting: Application to PPAR alpha-deficient mice by Blavy, Pierre et al.
A minimal model for hepatic fatty acid balance during
fasting: Application to PPAR alpha-deficient mice
Pierre Blavy, F. Gondret, Herve´ Guillou, S. Lagarrigue, P.G.P. Martin, J. Van
Milgen, Ovidiu Radulescu, A. Siegel
To cite this version:
Pierre Blavy, F. Gondret, Herve´ Guillou, S. Lagarrigue, P.G.P. Martin, et al.. A minimal
model for hepatic fatty acid balance during fasting: Application to PPAR alpha-deficient mice.
Journal of Theoretical Biology, Elsevier, 2009, 261 (2), pp.266. <10.1016/j.jtbi.2009.07.025>.
<hal-00559147>
HAL Id: hal-00559147
https://hal.archives-ouvertes.fr/hal-00559147
Submitted on 25 Jan 2011
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
www.elsevier.com/locate/yjtbi
Author’s Accepted Manuscript
A minimal model for hepatic fatty acid balance during
fasting: Application to PPAR alpha-deficient mice*
P. Blavy, F. Gondret, H. Guillou, S. Lagarrigue,
P.G.P. Martin, J. van Milgen, O. Radulescu, A.
Siegel
PII: S0022-5193(09)00331-2
DOI: doi:10.1016/j.jtbi.2009.07.025
Reference: YJTBI 5636
To appear in: Journal of Theoretical Biology
Received date: 21 March 2009
Revised date: 25 June 2009
Accepted date: 16 July 2009
Cite this article as: P. Blavy, F. Gondret, H. Guillou, S. Lagarrigue, P.G.P. Martin, J.
van Milgen, O. Radulescu and A. Siegel, A minimal model for hepatic fatty acid balance
during fasting: Application to PPAR alpha-deficient mice*, Journal of Theoretical Biology,
doi:10.1016/j.jtbi.2009.07.025
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting galley proof
before it is published in its final citable form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that apply
to the journal pertain.
Ac
ce
pte
d m
an
us
cri
pt 
A minimal model for hepatic fatty acid balance during
fasting: application to PPAR alpha-deﬁcient mice*
P. Blavya,g, F. Gondreta, H. Guilloub, S. Lagarriguec,d,e, P. G. P. Martinb,
J. van Milgena, O. Radulescu∗∗h,g, A. Siegelf,g
aINRA, UMR1079 Syste`mes d’Elevage, Nutrition Animale et Humaine (SENAH),
F-35590 Saint Gilles, France
bINRA, UR66 Laboratoire de Pharmacologie et Toxicologie,
180 Chemin de Tournefeuille, BP3, F-31931 Toulouse cedex 9, France
cAgrocampus Ouest, UMR 598 Ge´ne´tique Animale, F-35000 Rennes, France
dINRA, UMR 598 Ge´ne´tique Animale, F-35000 Rennes, France
eIFR 140, GFAS, F-35000 Rennes, France
fCNRS, UMR 6074 IRISA,
Campus de Beaulieu, F-35042 Rennes, France
gINRIA Rennes Bretagne Atlantique, Symbiose-project,
Campus de Beaulieu, F-35041 Rennes, France
hUniversite´ de Rennes 1, UMR 6625 IRMAR,
Campus de Beaulieu, F-35042 Rennes, France
Abstract
The purpose of this study is to identify the hierarchy of importance amongst
pathways involved in fatty acid (FA) metabolism and their regulators in the con-
trol of hepatic FA composition. A modeling approach was applied to experimen-
tal data obtained during fasting in PPARα-knockout (KO) mice and wild-type
mice. A step-by-step procedure was used in which a very simple model was
completed by additional pathways until the model ﬁtted correctly the measured
quantities of FA in the liver. The resulting model included FA uptake by the
liver, FA oxidation, elongation and elongation and desaturation of FA, which
were found active in both genotypes during fasting.
From the model analysis we concluded that PPARα had a strong eﬀect on
FA oxidation. There were no indications that this eﬀect changes during the
fasting period, and it was thus considered to be constant.
In PPARα KO mice, FA uptake was identiﬁed as the main pathway respon-
sible for FA variation in the liver. The models showed that FA were oxidized
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at a constant and small rate, whereas elongation and desaturation of FA also
occurred during fasting.
The latter observation was rather unexpected, but was conﬁrmed experimen-
tally by the measurement of delta-6-desaturase mRNA using real-time quanti-
tative PCR (QPCR). These results conﬁrm that mathematical models can be
a useful tool in identifying new biological hypotheses and nutritional routes in
metabolism.
Key words: fatty acid metabolism, systems biology, fasting, knockout
mice, modelling.
1. Introduction
Fatty acids (FA) are the main constituents of lipids in the body and are
building blocks for glyco- and phospholipids of cell membranes. FA also play an
important role in energy metabolism, allowing the storage of energy in a very
dense form as triglycerides, which can be oxidized later when energy is needed.
The FA can also act as signaling molecules and behave as regulators of several
transcription factors (Duplus et al., 2000). Therefore, they play crucial roles in
normal growth and development (e.g., (Uauy et al., 2007)) but also in coronary
artery disease (Seidelin, 1995; Shirai, 2004), dyslipidemia, hepatic steatosis and
other pathologies (Seidelin, 1995; Simopoulos, 1991).
The balance between synthesis and degradation of FA is regulated by nutri-
ent supply and the energy needs of the organism. In humans and mice, the liver
plays a central role in the endogenous synthesis of FA (Muiruri and Leveille,
1970). During fasting, FA are released from adipose tissue (AT) by lipolysis,
and serve as sources of energy in other organs. Circulating free FA are exten-
sively taken up by the liver in fasting rodents (Remesy and Demigne, 1983). In
the liver, FA can be a sourc of substrates for the synthesis of ketone bodies
ketone, which can be used as fuel by extrahepatic tissues.
The synthesis, degradation, and transformation of FA in hepatic cells are
catalyzed by over 300 enzymatic reactions (Kanehisa et al., 2008) involved in
distinct pathways (e.g., FA oxidation and elongation). These reactions are reg-
ulated at the metabolic and genetic levels by various hormones (e.g., insulin
(Campbell et al., 1992), leptin (Unger et al., 1999)) and nutrients (e.g., poly
unsaturated FA (Sessler and Ntambi, 1998)). However, the simple aggregation
of abundant literature data cannot account for all underlying interactions re-
sponsible for both FA metabolism and lipid phenotype. A better and more
comprehensive understanding of FA metabolism is needed to identify routes
that will allow for the nutritional modulation of lipid deposition that may help
preventing or curing lipid-related disorders. Therefore, it is critical to identify
the main pathways and regulators involved in the control of FA metabolism. To
achieve this goal, we used a modelling approach.
Mathematical models are powerful tools to combine information using a com-
mon formalism. Models are frequently used to describe, predict and test hy-
potheses. Depending on the objective, models can have diﬀerent levels of detail,
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ranging from very basic molecular mechanisms (e.g., (Fattal and Ben-Shaul,
1993)) to an empirical “black box” approach (e.g., (Forns et al., 2002)). Models
can be useful to explore and better understand FA metabolism and its regula-
tion within a cell, as well as between organs involved in lipid metabolism. To
provide a full description of the dynamics of the system considered as a homoge-
neous organ (e.g., (Calvetti et al., 2008)) or including the heterogeneous nature
of the organ (e.g., spatial models (Chalhoub et al., 2007b)), metabolic reac-
tions are modeled as diﬀerential equations or analyzed by convex optimization
techniques such as ﬂux balance analysis. Spatial models typically use partial
diﬀerential equations.
A contrasted situation is necessary to identify the key mechanisms involved
in the regulation of FA metabolism. In the present study, we considered the
kinetics of FA metabolism during fasting in both wild-type and peroxisome
proliferator-activated receptor alpha (PPARα) knockout (KO) mice. Fasting
triggers complex adaptive metabolic responses, including a switch to rely on
FA and ketone bodies for ATP synthesis ((Leone et al., 1999)) and an increased
capacity for mitochondrial FA oxidation in tissues with high energy demands
(Hashimoto et al., 2000; Leone et al., 1999). The PPARα is considered as the
master regulator of FA homeostasis (Desvergne and Wahli, 1999; Leone et al.,
1999). A genome-wide transcriptomic approach in mice has recently pointed
out the role of PPARα in the liver in the regulation of FA oxidation and ke-
tone body production during fasting (Sokolovic´ et al., 2008). Animals lacking
PPARα appear to be unable to increase the capacity for cellular FA utilization
(Leone et al., 1999). Monitoring the variation in FA composition in tissues of
wild-type and PPARα KO mice during fasting provides a useful experimental
data set to understand the regulation of FA metabolism and to develop compu-
tational models describing this metabolism.
To our knowledge, there is only one model (Chalhoub et al., 2007a) focused
on lipid metabolism in the liver during fasting conditions. This detailed math-
ematical model was based on diﬀerential equations and simulated gluconeogen-
esis during a 24-h fasting period in the perfused rat liver. This model included
key reactions for FA metabolism such as FA uptake, synthesis of triglycerides,
and FA oxidation. Because of the large number of reactions involved, many of
these were aggregated in series. Moreover, this model did not intend to predict
the variation in FA composition in the liver and did not include the genetic
regulation of FA metabolism. It intended to predict concentrations and ﬂuxes
of intermediate metabolites involved in FA metabolism and gluconeogenesis in
response to changes in various substrate concentrations in the perfused liver.
The aim of the present study was to identify the most relevant pathways
and their regulators involved in hepatic FA metabolism. Based on experimental
data and information from the literature, a model (based on diﬀerential equa-
tions) was developed that allows to explain the variation in FA composition
of the mouse liver during a fed-to-fasting transition. Additional experimen-
tal measurements (mRNA expression of delta-6-desaturase, a key enzyme of
polyunsaturated FA synthesis) were carried out to evaluate hypotheses that
were formulated following model analyses.
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2. Materials and methods
2.1. Biological experiments
2.1.1. Experimental data
Experimental data were obtained in 8 week-old male wild-type C57BL/6J
(WT) and PPARα KO mice (Lee et al., 1995; Costet et al., 1998) over a 72
h fasting period. Three to 6 mice for each genotype were sacriﬁced at diﬀer-
ent times points (0, 3, 6, 9, 12, 18, 24, 36, 48, 60, 72 h) after the last meal.
Before fasting, all animals were fed ad libitum a rodent diet 2018 from Harlan
Teklad (Gannat, France). At each time point, animal body weight was recorded
and liver and epididymal White Adipose tissue (AT) were dissected, weighed,
frozen in liquid nitrogen immediately after dissection, and stored at -80◦C until
analysis. Total lipid content was determined in liver and AT as described pre-
viously (Martin et al., 2007). Proportions of individual FA were determined by
gas chromatography analysis of FA methyl esters. The quantities of each FA
(C14:0, C16:0, C16:1ω9, C16:1ω7, C18:0, C18:1ω9, C18:1ω7, C18:2ω6, C18:3ω3,
C20:1ω9, C20:3ω6, C20:4ω6, C20:5ω3, C22:6ω3) in the liver and AT were cal-
culated considering the relative proportions of FA in total lipids and the mass
of liver and AT. Time-related variations in FA quantity were analyzed using the
lm() linear regression implemented in R 2.8.1 (www.r-project.org).
2.1.2. Gene expression
Hepatic total RNA was extracted using Trizol reagent (Invitrogen) according
to the manufacturer’s instruction. Complementary cDNA was synthesized from
2 μg of total RNA using random primers and Superscript II (Invitrogen) reverse
transcriptase according to the manufacturer’s instructions. The mRNA levels of
Delta6 desaturase (D6D) were measured by quantitative real-time PCR (QPCR)
after 0, 24, 48, and 72 h of fasting using 3’-TCCAGTACCAGATCATCATGA-
CAA-5’ as forward primer and 3’-GGTGTAGAAGAAACGCATATAGTAGCTG-5’
as reverse primer. Ampliﬁcations were performed on an ABI Prism 7000 Se-
quence Detection System (Applied Biosystems, Courtaboeuf, France).
The QPCR data were normalized by TATA-box binding protein (TBP) expres-
sion levels (TBP-F: ACTTCGTGCAAGAAATGCTGAA, TBP-R: GCAGTTGTC-
CGTGGCTCTCT) and analyzed using the DART-PCR software (Peirson et al.,
2003).
2.2. Principles of model development
A step-by-step procedure was applied to include diﬀerent metabolic path-
ways and regulators until the model ﬁtted the data well and no reasonable
improvement could be obtained.
Due to the absence of at least one complex regulatory system, the PPARα
KO mice can be considered as a relatively simpler model compared to wild-
type mice. Therefore we ﬁrst ﬁtted the successive models on data obtained in
PPARα KO mice. In order to allow comparisons between genotypes within the
same model (or modeling framework), we then extrapolated to wild-type mice
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the values of the parameters that should be common to both genotypes. We
consider that the KO mice is just a simpler and easier to study submodel of
the wild type model. This resulted in a minimal model of a set of ordinary
diﬀerential equations describing FA metabolism in the liver(Table 1).
The main pathways used in our model of FA metabolism are consistent with
common biochemistry knowledge (Kanehisa et al., 2008; Murray et al., 2006),
and include (Fig. 1) FA uptake, FA oxidation in mitochondria and peroxi-
somes, ketogenesis, the tricarboxylic acid cycle (where ATP is produced from
acetyl-coA), synthesis of malonyl-CoA from acetyl-coA, synthesis of palmitic
acid (C16:0) from malonyl-CoA and acetyl-coA, glycolysis to produce acetyl-
coA from glucose, and elongation and desaturation of polyunsaturated FA.
Several key regulators of FA metabolism have been described in the lit-
erature. They include PPARα, which is a transcription factor that activates
FA oxidation (Leone et al., 1999; Desvergne and Wahli, 1999; Lee et al., 1995)
and FA elongation and desaturation (Wang et al., 2006; Guillou et al., 2002).
Other regulators are SREBP1, which is a transcription factor that activates FA
synthesis (Horton et al., 2002; Jakobsson et al., 2006) as well as FA elongation
and desaturation (Matsuzaka et al., 2002) and malonylCoA, which inhibits FA
oxidation.
Because of the experimental conditions and the resulting data in the present
study, a decision was made as to which variables should be included in the
model. Metabolic pathways and regulators that were supposed to be inac-
tive or constant during fasting were not considered (Fig. 1). During the early
hours of fasting (3 to 6 h), the level of SREBP1 markedly decreases in the liver
(Horton et al., 1998), which results in a fasting-mediated transcriptional down-
regulation of the gene encoding FA synthase (i.e., the key enzyme of de novo FA
synthesis (Shimano et al., 1999; Horton et al., 2002; Kim et al., 1998)). There-
fore, SREBP1 was assumed to be negligible in our experimental conditions, and
de novo FA synthesis was supposed not to occur in our experimental conditions.
Hence, the inﬂuence of SREBP1 on elongation and desaturation was not consid-
ered. Moreover, since malonylCoA is an intermediate in de novo FA synthesis,
the malonylCoA-dependent inhibition of mitochondrial FA uptake was not con-
sidered. Acetyl-coA is a pivot in intermediary metabolism between catabolic
and anabolic processes (van Milgen, 2002). However, because the quantity of
acetyl-coA has no direct eﬀect on the FA composition in the liver, there was no
need to consider the 3 pathways aﬀecting acetyl-coA (i.e., glycolysis, ketogenesis
and the tricarboxylic acid cycle).
2.3. Model description
2.3.1. Choice of variables
In the various models we considered, we included all measured metabolites,
except those involved in intermediate metabolism (i.e. molecules participating
in a considered reaction that are neither a product nor a substrate). Therefore,
when the elongation and desaturation pathway was added, we included the
sum of Sω3 = C20:5ω3 + C22:6ω3 and Sω6 = C20:3ω6 + C20:4ω6 and not
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the individual quantities of C20:5ω3 and C20:3ω6, which were considered as
intermediates. Individual quantities of other FA were included in the model.
The quantity of PPARα was not explicitly included as a variable in the
model. However, the diﬀerence in numerical values of model parameters between
wild-type and PPARα mice represent the eﬀect of PPARα.
2.3.2. Fluxes
Liver uptake. Uptake of FA in the liver from the blood was diﬃcult to assess in
the experiments. During fasting, free FA are released from AT by lipolysis and
serve as energy sources for other organs including the liver. We considered that
the observed variation in FA composition in AT would reﬂect the FA uptake by
the liver. Input ﬂuxes of individual FA in liver (Φini ) were thus considered to be
proportional to FA released from AT by lipolysis during fasting. The parameter
KIn represents the proportionality factor relating FA release from AT to FA
uptake by the liver. The KIn was supposed to be the same for all FA. During
fasting, FA are released at a time-constant rate from AT that diﬀers between
FA. To evaluate this rate, a linear regression for each FA in AT (XATi ) was
performed as XATi = ai ∗ time + intercepti. The slope (ai) of this relation was
then used to estimate FA uptake by the liver:
Φini = KIn ∗ ai. (1)
Oxidation. The reaction ﬂux for total oxidation (ΦOxii ) of the ith FA in the liver
(XLi ) during fed-to-fast transition was expressed as a Michaelis-Menten equation
in simpliﬁed form, using a constant parameter representing the oxidation rate
(koxi) and a relative aﬃnity parameter for each FA (bi) :
ΦOxii = koxi
XLi bi∑
j X
L
j bj
with
∑
i
bi = 1. (2)
We hypothesized that the quantities of FA were not limiting for the reaction.
This assumption was supported by the fact that the sum of FA in the liver
increased from 0 to 72 h since the onset of fasting (Table 2).
The FA do not always undergo complete oxidation resulting in acetyl-coA
and ATP. Consequently, shorter-chain FA intermediates may be generated,
which can accumulate in the liver. We considered incomplete oxidation of a
FA as the reaction producing a FA that is two carbons shorter than the original
FA. Therefore, the total oxidation ﬂux ΦOxii was separated into 2 ﬂuxes repre-
senting either complete (ΦCompleteOxii ) or incomplete (Φ
IncompleteOxi
i ) oxidation
ﬂuxes:
ΦCompleteOxii = si ∗ Φ
Oxi
i (3)
ΦIncompleteOxii = (1 − si) ∗ Φ
Oxi
i , (4)
where si represents the proportion of complete oxidation of the total oxidation.
In the models considered (Table 1), we had to choose between three hypothe-
ses : the ith FA is only oxidized completely (si = 1), the ith FA is only partially
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oxidized leading to the generation of a two carbons shorter FA (si = 0), or the
ith FA is both partially and totally oxidized (si ∈]0; 1[). These hypotheses will
be tested going from the simplest (si = 1) to the most complicated hypothesis
(si ∈]0; 1[) in a step-by-step procedure (section 2.3.3). As will be shown later,
the third hypothesis was not necessary to obtain a correct ﬁt of the model to
the data.
Elongation and desaturation. Unsaturated FA consist of monounsaturated and
polyunsaturated FA. Based on the location of the last double bound, polyunsat-
urated FA are classiﬁed as ω3 or ω6. Within each class, FA can be transformed
through elongation and desaturation reactions (Fig. 2). The enzyme D6D has
been considered a rate-limiting enzyme (Cho et al., 1999) of the FA elonga-
tion/desaturation pathway, which coincide with the observation that hepatic
quantities of C18:2ω6 and C18:3ω3 increased from 0 to 72 h of fasting (Ta-
ble 2). Because D6D is common to ω3 and ω6 desaturation pathways, C18:2ω6
and C18:3ω3 are in competition for this enzyme. Elongation and desaturation
ﬂuxes (ΦDesatC18:2ω6 and Φ
Desat
C18:3ω3) of C18:2ω6 and C18:3ω3 were included in the
rate of elongation and desaturation (kdesat), and the relative aﬃnity of D6D for
the ith FA (di) can be given as:
ΦDesatC18:3ω3 = kdesat
C18 : 3ω3 ∗ dC18:3ω3
C18 : 3ω3 ∗ dC18:3ω3 + C18 : 2ω6 ∗ dC18:2ω6
(5)
ΦDesatC18:2ω6 = kdesat
C18:2ω6∗dC18:2ω6
C18:3ω3∗dC18:3ω3+C18:2ω6∗dC18:2ω6
with
∑
i di = 1. (6)
2.3.3. Choosing the optimal level of detail by a step-by-step procedure
A step-by-step procedure was applied until the model included just enough
detail to ﬁt the change in FA quantities over time .
• Step 1: We started with a model including only one ﬂux (i.e., uptake of
FA from AT by the liver).
• Step 2: We estimated model parameters from the experimental data (see
the parameter estimation method below).
• Step 3: If a parameter set was found allowing a close ﬁt of model predic-
tions to the observed data, the model (and its parameters) was accepted
and the procedure ended (see the ﬁtting criterion below). If not, model
output was analyzed, and additional pathways and regulators were in-
cluded. The selection of pathways and regulations was based on model
behavior and biological knowledge. We then went back to step 2.
Parameters estimation. An initial guess of parameter estimates was found by
a linear approximation of the model under the assumption that
∑
j∈FA X
L
j bj
is constant. This sum was evaluated by replacing XLj by the mean of ob-
served value for the jth FA. Parameters were then estimated using the Nelder
7
Ac
ce
pte
d m
an
us
cri
pt 
and Mead optimisation (Nelder and Mead, 1965) implemented in R 2.8.0 optim
procedure, by minimizing the sum of squared deviations between observed data
and predicted values.
Goodness of ﬁt. Fitting quality was estimated using the coeﬃcient of variation
of the mean squared prediction error (cvMSPE) (Tedeschi, 2006; Bibby, 1977).
The mean squared prediction error measures the distance between observed and
predicted values, and can be decomposed in central error (CE), regression error
(RE), and disturbance error (DE). The CE describes the contribution of distance
between mean values of observed and predicted data. The RE describes how
the slope of the linear regression between predicted and observed data diﬀers
from one. The DE is the remaining error. The cvMSPE was used to standardize
the results, so that diﬀerent FA could be compared. Models resulting in a low
cvMSPE combined with an important contribution of DE are preferred and we
considered results acceptable if DE > 25% (an arbitrarily chosen value).
3. Results and discussion
In both mouse genotypes, FA quantities in the liver were generally greater
after a 72 h fasting period compared with the fed state (Table 2). For only three
FA, there was no diﬀerence in the quantity of FA between 0 and 72 h. This
concerned C20:4ω6 in wild-type mice and C20:4ω6 and C20:5ω3 in PPARα KO
mice. There are indications in the literature showing that FA can accumulate
in the liver during fasting in both PPARα KO and wild-type mice using Sudan
Black staining of lipids (Lee et al., 2004) or Oil Red O staining of neutral lipids
(Hashimoto et al., 2000). The amplitudes of fasting-induced FA accumulations
observed in the present study are consistent with a previous study of wild-type
and PPARalpha knockout mice under the fed and starved (72h) conditions (see
(Lee et al., 2004)).
This likely reﬂects the major role played by the liver during fasting to cope
with the metabolism of FA coming from adipose tissue lipolysis. The quan-
tities of most FA increased more markedely in PPARα KO livers compared
to wild-type controls (Table 2). As shown below, this likely results from the
impared hepatic FA beta-oxidation in PPARα KO mice. Saturated and espe-
cially monounsaturated FA were most strongly increased than polyunsaturated
FA in both genotypes. Only C20:5w3 and C22:6w3 increased more strongly in
wild-type than in PPARα KO livers during fasting (Table 2).
3.1. Model structure
According to the step-by-step procedure, three successive models were built,
diﬀering in degree of complexity. Model 1 included only FA uptake, whereas
model 2 included both FA uptake and FA oxidation. Model 3 was similar to
model 2 but also included elongation and desaturation of FA. The equations
used for these models are given in Table 1. These models are shown in Figure
3.
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For each model, the values of the parameters were ﬁrst estimated in the
simpler PPARα KO mice model. The parameter values were then extrapolated
to wild-type mice. When the model with extrapolated parameter values did not
ﬁt to the data for wild-type mice, then new parameter values were estimated
from wild-type data (Table 3).
3.2. Model 1: accumulation of FA by the liver
This model included uptake of FA by the liver proportional to AT eﬄux.
The proportionality constant was assumed to be the same for all FA. This
constant was evaluated in PPARα KO mice and then extrapolated to wild-type
mice.
3.2.1. During fasting, FA release from AT diﬀers between genotypes
Fatty acid composition in mouse liver (Table 2) and AT (Table 4) in the
fed state was diﬀerent in PPARα KO mice than in wild-type mice. The FA
quantities (except for C20:5ω3 and C22:6ω3) were generaly greater in the liver
and lower (except for C18:2ω6 and C18:3ω3) in AT of KO mice compared with
the wild-type mice. The variation in FA quantities in AT during fasting could
be described by linear functions of time, as shown by the high correlation coef-
ﬁcients in Table 4. The regression slopes (Table 4) were lower in PPARα KO
mice than in WT animals, suggesting that lipolysis from AT was less active
during fasting in the absence of PPARα.
A lesser reduction in epididymal fat pad weights in KO mice compared with
wild-type has been observed by others (Lee et al., 2004), suggesting that mobi-
lization of fat depots is delayed during starvation in mice that lack PPARα.
This potential eﬀect of PPARα on adipose tissue lipolysis during fasting
contrasts with its low expression in this tissue (Bookout et al., 2006). How-
ever, it has been shown that despite a low expression level PPARα regulates
glycerol kinase (GyK) in white adipose tissue (Mazzucotelli et al., 2007). In-
terestingly, PPARα KO mice exhibit a higher basal AT Gyk expression com-
pared to wild-type mice (Mazzucotelli et al., 2007). Since GyK is involved in
FA recycling, its activity may contribute to counteract the eﬀect of lipolysis in
PPARα KO AT. On the other hand, PPARα-dependent regulations in other
tissues expressing PPARα could have indirect eﬀects on AT through interorgan
communications. For example, it has been proposed that PPARα may regulate
speciﬁc genes in the brain which could could result in increased Glut4 expres-
sion in the AT (Knauf et al., 2006). In this study, high Glut4 expression was
proposed to increase glucose clearance in the adipose tissue of PPARα KO mice
thus contributing to their hypoglycemia during fasting. Increased glucose input
in adipose tissue of fasted PPARα KO mice may also contribute to counteract
the eﬀects of lipolysis on AT lipid content by stimulating inappropriately FA
synthesis.
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3.2.2. During fasting, FA hepatic input ﬂux is assumed to be proportional to the
FA release from AT
During fasting, FA released by lipolysis in AT serve as an energy source
for other organs, including the liver. The free FA uptake by the liver has
been described by others as a linear function of the total free FA concentra-
tion in blood (Berk and Stump, 1999), until saturation of the uptake system
(Sorrentino and Berk, 1993).
In the absence of information in our experiments on the free FA ﬂux in blood
(i.e., FA concencentrations and blood ﬂow), we assumed that hepatic input ﬂux
of FA was proportional to the FA release from AT during fasting, using a same
KIn proportionality constant for all FA and both genotypes.
3.2.3. FA uptake is the major phenomenon involved in the variation of FA in
PPARα KO mice, but not in wild-type mice where oxidation is important
too
The cvMSPE estimates (Table 5) showed that the sum of all FA and all
individual FA quantities except C16:1ω7, C16:1ω9, C22:6ω3, and C18:3ω3 were
correctly ﬁtted in PPARα KO mice. By contrast, in wild-type mice neither the
sum nor the individual FA are correctly ﬁtted. This result was anticipated for
wild-type mice, as during fasting, liver FA oxidation is known to be more active
in wild-type mice than in PPARα ones (Le May et al., 2000). Therefore, uptake
of FA was the major phenomenon involved in the variation of hepatic FA during
fasting in PPARα KO mice, but not in wild-type mice.
3.2.4. Hepatic FA input can be modeled as a simple proportional function of FA
variation in AT
The good ﬁtting of most FA in PPARα KO mice conﬁrmed that hepatic FA
input can be modeled as a simple proportional function of FA variation in AT.
This also suggests that FA uptake is the main pathway responsible for varia-
tion in hepatic FA composition in PPARα KO mice during the fed-to-fasting
transition. It also suggests that selective importation of FA was negligible.
3.2.5. C16:1ω7 has a speciﬁc two times dynamic.
The quantity of C16:1ω7 was poorly ﬁtted in PPARα KO mice and was
overestimated from 50 to 72 h (Fig. 5).The kinetics of C16:1w7 hepatic accu-
mulation seems to follow a speciﬁc time pattern with accumulation from 0 to
50 h, to remain constant thereafter. This pattern cannot be explained by im-
portation or speciﬁc oxidation, which should have occurred at a constant rate
during the fed-to-fasting transition. Recently, it was shown that C16:1ω7 can
act as an AT-derived signal and has, unlike other FA, a systemic metabolic ef-
fect (Cao et al., 2008). It is possible that C16:1ω7 has a very speciﬁc metabolic
fate and not only targets the liver but also other tissues such as muscle. This
hypothesis remains to be explored further experimentally , and the lack-of-ﬁt
for C16:1ω7 was therefore not further addressed in our model.
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3.2.6. The bad ﬁtting of C16:1ω9 and C22:6ω3 in PPARα KO mice is unlikely
to be explained by a speciﬁc FA uptake
The poor ﬁtting of the quantities of C16:1ω9 and C22:6ω3 in the liver of
PPARα KO mice can be explained by speciﬁc higher rates of uptake or by
reactions that produce these FA from other FA. Cellular uptake of FA as well
as intracellular transport of FA is mediated through simple diﬀusion, facilitated
diﬀusion, or carrier-mediated transport (Berk and Stump, 1999). It has been
shown (Oikari et al., 2008) that cytosolic acyl-carrier binding protein (ACBP)
has a higher aﬃnity for C14-C22 FA than for medium chain FA (C8-C12). To
our knowledge, selective regulation of long-chain FA uptake has not yet been
described. When we calculate the selective uptake for C16:1ω9, and C22:6ω3
required to ﬁt the data, it appears that these values should have been 2 to 12
times greater than the common rate determined for the other FA. Therefore, we
assumed that transformations between FA leading to the production of C16:1ω9
and C22:6ω3 would be a more likely scenario to explain the accumulation of
these FA in the liver, rather than the selective uptake.
3.2.7. The bad ﬁtting of C16:1ω9 in PPARα KO mice is likely explained by
incomplete oxidation of C18:1ω9
C16:1ω9 can be produced by oxidation from C18:1ω9 (Fig. 2). In PPARα
KO mice, the proportion of C16:1ω9 in the liver is very small (1.7% of total liver
FA at 72 h of fasting), compared with that of C18:1ω9 (26% of total hepatic
FA at 72 h). Therefore, inclusion of the incomplete oxidation of C18:1ω9 into
C16:1ω9 might ﬁt the latter FA, without reducing the quality of ﬁt for C18:1ω9
(this reaction will be included in model 2).
3.2.8. The bad ﬁtting of C22:6ω3 in PPARα KO mice is likely explained by
elongation/desaturation of C18:3ω3
C22:6ω3 was underestimated in PPARα KO mice and can only be produced
by elongation and desaturation (Fig. 2) from C18:3ω3, which was overestimated.
Therefore, it seems plausible that the absence of the elongation/desaturation
pathway in model 1 is the cause of the observed lacks-of-ﬁt. These reactions
will be added in model 3 (section 3.4).
3.2.9. Building the next model
Model 2 will include incomplete oxidation of C18:1ω9 to C16:1ω9 in PPARα
KO mice, and complete oxidation of all FA in wild-type mice.
3.3. Model 2: accumulation and (complete or partial) oxidation of FA by the
liver
This model included both FA uptake (see model 1 in section 3.2) and FA
oxidation in the liver of both genotypes.
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3.3.1. Both PPARα KO and wild-type mice have an active oxidation during
fasting but with much higher rates in wild-type mice
In PPARα KO mice, only the partial oxidation of C18:1ω9 was considered
(bC18:1ω9 = 1 whereas bi = 0 for the other FA). This oxidation was considered
to be incomplete, and produced C16:1ω9, which was modeled as sC18:1ω9 = 0.
As anticipated, the Disturbance error (DE) of C16:1ω9 was greater for model
2 (87%, Table 6) than from model 1 (8%, Table 5).Comparatively, the DE for
C18:1ω9 did not decrease notably (from 44 to 36%, Tables 5 and 6). In wild-type
mice, the complete oxidation of all FA was required to obtain a better ﬁt of the
model, as shown by the increase of the DE for most of the FA (Tables 5 and 6).
The estimated rate of oxidation of C18:1ω9 in PPARα KO mice was only 1% of
that estimated in wild-type mice during a 72 h fasting period, conﬁrming tha
wild-type mice had a much higher hepatic FA oxidation compared to PPARα
KO mice.
Fasting is thought to induce a rise of hepatic lipids sensed by PPARα that, in
turn, stimulates the expression of oxidative genes (Kersten et al., 1999). Studies
using PPARα KO mice have provided evidence that the absence of functional
PPARα decreases basal levels of β-oxidation of C16:0 in PPARα KO mice,
but induces no diﬀerence in the metabolism of C24:0 compared with wild-type
mice (Aoyama et al., 1998). The hepatic expression of most oxidative genes was
not induced by fasting in PPARα KO mice (Leone et al., 1999). Finally, beta-
hydroxybutyrate (i.e., an important ketone product of liver FA oxidation) in
PPARα KO mice is 14% of that in wild-type mice fasted for 24 h (Kersten et al.,
1999).
Considered together, the introduction of a small oxidation rate for PPARα
KO mice during fasting is not inconsistent with the literature results indicated
above. It should be kept in mind that this option will likely underestimate the
oxidation rate, because a model with a higher FA uptake rate and a higher
oxidation rate would produce similar results. Furthermore, it is possible that
oxidation of FA other than C18:1ω9 also occurred in PPARα KO mice during
fasting. However, this was not considered because results from model 1 sug-
gested that these oxidation rates are small. Introducing additional oxidation
reactions was not necessary to obtain reasonable model predictions (Table 2).
In wild-type mice, the simplest hypothesis of complete oxidation (si = 1)
of FA was suﬃcient to model the FA content in the liver. Therefore, a step-by-
step procedure did not include the use of more reﬁned hypotheses by combining
complete and incomplete oxidation. The calculated aﬃnity coeﬃcients for the
various FA regarding oxidation are given in Table 3 and the cvMSPE values are
in Table 6. The accuracy of the model was generally good, except for C20:5ω3
and C22:6ω3, which have DE proportions smaller than 25%. It is known that
FA are oxidized in peroxisomes or mitochondria at diﬀerent rates according
to chain length and degree of unsaturation (Mahler et al., 1953; Fritz, 1959;
Shindo and Hashimoto, 1978; Mannaerts et al., 1979; Hiltunen et al., 1986). To
our knowledge, the relative rates of oxidation of FA are unknown. Even though
FA may be oxidized at diﬀerent rates, the model ﬁtted the experimental data
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well without the need for a time-dependent regulation of oxidation during the
fed-to-fasting transition. This suggests that the PPARα-dependent induction of
FA oxidation during fasting is either small compared to its constitutive eﬀect,
or that it saturates relatively quickly during fasting. The saturation hypothesis
may be tested in a speciﬁc study focusing on the ﬁrst 10 to 20 h of fasting by
evaluating the expression of genes and enzymes involved in the oxidation of FA.
3.3.2. Building the next model
Model 2 only included FA uptake and oxidation in the liver, but many of the
short-comings of model 1 could be resolved by including the oxidation of FA. As
discussed for model 1, the poor quality of ﬁt for C22:6ω3 cannot be resolved by
oxidation and the results for this FA were not better in model 2 than they were
in model 1 (Table 6). As indicated above, C22:6ω3 can only be produced by
elongation and desaturation (Fig. 2) from C18:3ω3.Thus, to build model 3 we
added the elongation and desaturation pathway to model 2. In wild-type mice,
the oxidation rate had to be estimated again to account for the use of C18:3ω3
by both oxidation and elongation and desaturation.
3.4. Model 3: accumulation, oxidation, and desaturation and elongation of FA
by the liver
Essential FA metabolism involves the desaturation and elongation to syn-
thesize very long-chain polyunsaturated FA from C18:3ω3 and C18:2ω6. Be-
cause delta-6 desaturase (D6D) is common to ω3 and ω6 desaturation pathways,
C18:2ω6 and C18:3ω3 are in competition for this rate-limiting enzyme (Fig. 2).
3.4.1. Elongation and desaturation process is active during fasting in both geno-
types
For both genotypes model 3 (FA uptake, oxidation and elongation/desa-
turation) ﬁtted the observed accumulation of C22:6ω3 better (Table 7) than
model 2 (Table 6). This suggests that elongation and desaturation of C18:3ω3
to C22:6ω3 are active in both genotypes during fasting. The need to include an
active elongation and desaturation pathway in the liver of mice under fasting
conditions in PPARα KO mice is surprising.
The rate of desaturation and elongation is generally considered to be lim-
ited by D6D (Cho et al., 1999), which is transcriptionally-activated by SREBP1
(Matsuzaka et al., 2002). The nuclear form of SREBP-1 in the liver of mice has
a very low, barely detectable level after 6 h of fasting (Horton et al., 1998).
A second transcriptional activator of D6D is PPARα (Matsuzaka et al., 2002).
Considering that PPARα was invalidated in PPARα KO mice, and that SREBP-
1 is inhibited by fasting (Horton et al., 1998), transcription and activity of D6D
should have rapidly decreased during the ﬁrst hours of fasting in PPARα KO
livers.
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3.4.2. Experimental validation: mRNA expression of D6D is stable during the
ﬁrst 24h of fasting
To support at least in part the results of our model, mRNA levels of D6D
were monitored by real-time quantitative PCR in the liver of mice after 0, 24, 48,
and 72 h of fasting. As shown in Fig. 4, D6D mRNA levels remained constant
during the ﬁrst 24 h of fasting in the two genotypes.
D6D mRNA levels signiﬁcantly decreased at 72h and 48h in wild-type and
PPARα KO livers respectively. Therefore, D6D expression seems to be regu-
lated in a time-dependent manner during fasting and its regulation partially
depends on PPARα expression only after 24h. This result is consistent with the
need to incorporate the desaturation/elongation pathway in our model for both
genotypes to correctly ﬁt the FA data. Additionally, these data suggest that
the mechanisms by which D6D mRNA expression is regulated during fasting
involve other molecular players than the known major regulators PPARα and
SREBP1. These unknown regulators remain to be identiﬁed but could respond
to several hormonal or metabolic signals that are modulated during fasting, pos-
sibly diﬀerentially between wild-type and PPARα KO mice. Several hormones
have been shown to reduce D6D expression or activity in the liver (for a review
see (Brenner, 2003)) including glucagon and glucocorticoids which are increased
during fasting. However, to our knowledge, the accurate kinetics of these hor-
monal changes have not yet been described in wild-type and PPARα knockout
mice. Hence, it is diﬃcult to predict whether such hormonal signal may diﬀer-
entially inﬂuence D6D expression between these two genotypes. On the other
hand, several metabolic parameters diﬀer between fasted wild-type and PPARα
KO mice. For instance, the latter exhibit hypoglycemia and reduced metabolic
rates during fasting (Kersten et al., 1999) in addition to impaired FA oxidation
(Le May et al., 2000). In the liver, glucose and FA (Guillou et al., 2008) may
inﬂuence the transcription of enzymes involved in FA metabolism. Changes in
glucose, FA or other metabolites that may inﬂuence the diﬀerential expression
of D6D reported here remains to be investigated.
4. Conclusion
A simple model including fatty acids uptake, oxidation and elongation/de-
saturation was able to predict correctly the variation of most fatty acids in the
liver of both PPARα KO and wild-type mice. This model included parameter
estimates in adipose tissue and liver to explain the change in fatty acid content
in the liver during fasting.
Experimental measurements in diﬀerent organs obtained in the same ani-
mals and under the same experimental conditions are strongly needed in the
future to predict the dynamics of fatty acids in a given organ. The presence
of a basal oxidation in both PPARα KO and wild-type mice with a rate that
depended on the genotype but not on the time of fasting shows that PPARα
has a constitutional eﬀect on oxidation but little or no time-dependent eﬀects.
The presence of an active elongation and desaturation in both genotypes was
surprising in the liver of fasting mice. It conﬁrms and strengthens earlier results
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(Nakamura and Nara, 2003) suggesting that the unsaturated fatty acids content
in tissues is maintained within physiological ranges by feedback regulation of
synthetic pathways.
The regulation of desaturases by PPARα is diﬀerent from the main role
of PPARα in inducing oxidation (Nakamura and Nara, 2003) and cannot be
explained by the diﬀerential behavior of various desaturases such as delta-6-
desaturase and stearoyl-coenzyme A desaturase (Radulescu et al., 2006). Our
results suggest that mechanisms other than PPARα activation are likely to
contribute to the regulation of delta-6-desaturase activity during fasting.
In the future, the model could be used to design speciﬁc experiments aiming
at a better understanding of lipid metabolism as regulated by the nutritional
status. The same set of equations could be used in other tissues such as muscle,
in other animal species, to predict inter-species variability in lipid metabolism
or in animals fed diets with diﬀerent FA compositions.
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Table 1: Summary of models obtained with the step-by-step procedure. The models predict
variations in hepatic fatty acid (FA) composition during fasting.
Model 1 Diﬀerential equations
∀i ∈ {all FA}
dXL
i
dt
= Φin
i
Model 2 Diﬀerential equations
∀i ∈ { C14:0, C16:0, C16:1w7, C18:0, C18:1ω7,
C18:3ω3, C18:2ω6, C20:5ω3, C22:6ω3, C20:3ω6,
C20:4ω6}
dXL
i
dt
= Φin
i
−ΦOxi
i
with si = 1
i = C18:1ω9
dXL
i
dt
= Φin
i
−ΦOxi
i
with si = 0 in PPARα KO mice
and si = 1 in wild-type mice
i = C16:1ω9
dXL
i
dt
= Φin
i
−ΦOxi
i
+ ΦIncompleteOxi
C18:1ω9
with si = 1
Model 3 Diﬀerential equations
∀i ∈ { C14:0, C16:0, C16:1w7, C18:0, C18:1ω7}
dXL
i
dt
= Φin
i
−ΦOxi
i
with si = 1
∀i ∈ {C18:3ω3, C18:2ω6}
dXL
i
dt
= Φin
i
−ΦOxi
i
− ΦDesat
i
with si = 1
∀i ∈ {Sω3, Sω6}
dXL
i
dt
= Φin
i
−ΦOxi
i
+ ΦDesat
i
with si = 1
i = C18:1ω9
dXL
i
dt
= Φin
i
−ΦOxi
i
with si = 0 in PPARα KO mice
and si = 1 in wild-type mice
i = C16:1ω9
dXL
i
dt
= Φin
i
−ΦOxi
i
+ ΦIncompleteOxi
C18:1ω9
with si = 1
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Table 2: Fatty acid contents (μmoles) in the liver of wild type or PPARα knockout mice
during fasting
Genotype PPARα knockout Wild type
Fasting time (h) 0 72 72h/0h a P valueb 0 72 72h/0h P valuea
Fatty acid
C14:0 0.43 10.17 23.45 <0.001 0.26 3.07 11.81 <0.001
C16:0 31.77 129.76 4.08 <0.001 23.26 53.49 2.30 <0.001
C16:1ω9 0.51 16.53 32.41 <0.001 0.38 5.31 13.97 <0.001
C16:1ω7 1.34 21.06 15.72 <0.001 1.91 6.73 3.52 0.001
C18:0 15.79 34.54 2.19 <0.001 8.69 15.92 1.83 <0.001
C18:1ω9 14.09 257.35 18.26 <0.001 11.99 85.43 7.13 <0.001
C18:1ω7 1.74 19.12 10.99 <0.001 1.94 6.24 3.22 <0.001
C18:2ω6 38.57 455.88 11.81 <0.001 15.11 114.84 7.60 <0.001
C18:3ω3 1.21 9.99 8.26 <0.001 0.41 2.50 6.10 <0.001
C20:1ω9 0.61 6.17 10.11 <0.001 0.29 2.87 9.90 <0.001
C20:3ω6 1.06 1.99 1.88 0.017 1.22 1.04 0.85 0.037
C20:4ω6 12.45 15.54 1.25 0.825 9.16 10.81 1.18 0.196
C20:5ω3 0.26 0.36 1.38 0.115 0.20 0.97 4.85 <0.001
C22:6ω3 6.30 10.97 1.74 0.021 4.09 14.31 3.50 <0.001
aRatios between the 72h and 0h of fasting are presented although these ratios may
be largely inﬂuenced by some very low concentrations observed under the fed condition
(t=0h).
bP value associated to the slope of the linear regression :Fatty acid quan-
tity = slope×time + intercept in each genotype. This value was considered to be signiﬁ-
cant for P value < 0.05.
Table 3: Calculated parameters of the diﬀerent models built to depict fatty acid composition
in the liver of wild-type or PPARα knockout mice during fasting
Genotype PPARα knockout mice Wild type mice
Parameters Model1 Model2 Model3 Model1 Model2 Model3
Kin 2.9e+00 2.9e+00 2.9e+00 2.9e+00 2.9e+00 2.9e+00
Koxi(mmol.h
−1) 0 1.05e-04 1.05e-04 0 9.92e-03 9.92e-03
si (i = C18:1ω9) 1 1 1 1 1 1
sC18:1ω9 0 0 0 1 1 1
bC14:0 0 0 0 1.43e-01 1.43e-01 1.43e-01
bC16:0 0 0 0 6.96e-02 6.96e-02 6.96e-02
sC16:1ω9 0 0 0 2.51e-02 2.51e-02 2.51e-02
sC16:1ω7 0 0 0 2.22e-01 2.22e-01 2.22e-01
sC18:0 0 0 0 1.67e-02 1.67e-02 1.67e-02
sC18:1ω9 1 1 1 9.51e-02 9.51e-02 9.51e-02
sC18:1ω7 0 0 0 1.03e-01 1.03e-01 1.03e-01
sC18:2ω6 0 0 0 6.39e-02 6.39e-02 6.39e-02
sC18:3ω3 0 0 0 1.54e-01 1.54e-01 1.54e-01
sC20:1ω9 0 0 0 7.18e-02 7.18e-02 7.18e-02
sC20:3ω6 0 0 0 3.44e-02 3.44e-02 3.44e-02
sC20:4ω6 0 0 0 8.58e-04 8.58e-04 8.58e-04
sC20:5ω3 0 0 0 0 0 0
sC22:6ω3 0 0 0 0 0 0
sC22:6ω3 0 0 0 0 0 0
Kdesat(mol.h
−1) 0 0 4.92e-05 0 0 9.2e-05
dC18:3ω3 1 1 1 0.99956 0.99956 0.99956
dC18:2ω6 0 0 0 0.00044 0.00044 0.00044
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Table 4: Estimates of linear regressions for fatty acid contents during a 72 hours of fast in
adipose tissue of wild type or PPARα knockout mice
Genotype PPARα knockout Wild-type
Intercept Slope Ra Intercept Slope R
(μmoles) (nmol.h−1) (μmoles) (nmol.h−1)
Fatty acids
C14:0 3.91 -42.68 -0.81 4.64 -59.58 -0.98
C16:0 57.22 -623.63 -0.88 71.28 -962.29 -0.99
C16:1ω9 2.34 -23.38 -0.87 2.63 -31.80 -0.98
C16:1ω7 15.50 -183.58 -0.87 21.13 -311.27 -0.96
C18:0 5.76 -53.23 -0.85 6.49 -75.27 -0.99
C18:1ω9 87.23 -903.41 -0.87 105.20 -1352.02 -0.99
C18:1ω7 6.57 -67.63 -0.86 8.72 -113.66 -0.98
C18:2ω6 137.19 -1448.85 -0.87 114.91 -1485.97 -1.00
C18:3ω3 6.17 -72.85 -0.90 5.83 -83.98 -0.98
C20:1ω9 1.70 -14.58 -0.81 2.85 -28.57 -0.95
C20:3ω6 0.27 -2.37 -0.80 0.58 -6.74 -0.96
C20:4ω6 0.44 -4.00 -0.86 0.89 -11.36 -0.95
C20:5ω3 0.14 -1.14 -0.69 0.33 -3.61 -0.94
C22:6ω3 0.14 -0.76 -0.47 0.66 -7.51 -0.94
Average 23.18 -245.86 -0.81 24.72 -323.83 -0.97
aPearson correlation coeﬃcient.
Table 5: MSPE coeﬃcient of variation and its decomposition in the model 1 predicting fatty
acid composition in the liver of wild type or PPARα knock out mice during fasting. This
model included only fatty acid uptake from adipose tissue.
Genotype PPARα knock out mice Wild type mice
Statistics a cvMSPE CE(%) RE(%) DE(%) cvMSPE CE(%) RE(%) DE(%)
C14:0 2.77e-01 0 24 76 4.42e+00 55 44 0
C16:0 3.16e-01 6 57 37 2.15e+00 52 48 1
C16:1ω9 8.29e-01 43 49 8 8.23e-01 59 30 11
C16:1ω7 7.73e-01 12 60 28 6.89e+00 53 47 0
C18:0 1.35e-01 34 5 60 5.28e-01 62 35 3
C18:1ω9 2.59e-01 49 7 44 2.94e+00 54 45 1
C18:1ω7 2.22e-01 43 4 53 3.19e+00 56 44 0
C18:2ω6 2.91e-01 55 7 38 1.98e+00 51 48 1
C18:3ω3 6.62e-01 13 67 19 4.76e+00 51 49 1
C20:1ω9 3.95e-01 37 36 27 2.23e+00 60 38 2
C20:3ω6 1.88e-01 1 1 98 1.10e+00 67 30 3
C20:4ω6 9.94e-02 3 2 95 7.64e-02 0 44 56
C20:5ω3 4.7e-01 0 54 46 1.5e-01 13 4 83
C22:6ω3 2.58e-01 68 11 21 5.15e-01 58 40 2
Total FA 2.12e-01 37 0 63 2.07e+00 53 47 1
Total ω9 b 2.79e-01 51 12 37 2.83e+00 55 45 1
Total ω3 c 2.37e-01 2 52 47 3.68e-01 38 55 7
Total ω6 d 2.75e-01 54 6 39 1.66e+00 50 48 1
C20:5ω3+C22:6ω3 2.48e-01 68 8 25 4.86e-01 58 40 2
C20:3ω6+C20:4ω6 1.04e-01 2 1 97 1.34e-01 32 52 17
Total sat + mono e 1.94e-01 12 10 78 2.52e+00 54 46 0
aMean squared prediction error (MSPE) expressed as a coeﬃcient of variation (cv). This
value measures the distance between observed and predicted value. MSPE can be decom-
posed in central error (CE) + regression error (RE) + disturbance error (DE). CE describes
the contribution of distance between mean values of observed and predicted data. The RE
describes how the slope of the linear regression between predicted and observed data diﬀers
from one. DE is the remaining error. Fatty acid quantity is considered badly ﬁtted if DE ≤
25% ; this values are written in bold font.
bC16:1ω9 + C18:1ω9 + C20:1ω9
cSum of C18:3ω3 , C20:5ω3 , C22:6ω3
dSum of C18:2ω6 , C20:3ω6 , C20:4ω6
esum of saturated (C14:0 + C16:0 + C18:0) and monounsaturated (C16:1ω7, C16:1ω9,
C18:1ω7, C18:1ωP ) fatty acids.
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Table 6: MSPE coeﬃcient of variation and its decomposition in the model 2 predicting fatty
acids composition in mouse liver during fasting. This model includes fatty acid inﬂux from
adipose tissue and oxidation of fatty acids.
Genotype PPARα knock out mice Wild type mice
Statistics cvMSPEa CE(%) RE(%) DE(%) cvMSPE CE(%) RE(%) DE(%)
C14:0 2.77e-01 0 24 76 3.18e-01 0 10 90
C16:0 3.16e-01 6 57 37 2.52e-01 3 46 51
C16:1ω9 2.52e-01 0 13 87 3.15e-01 4 11 85
C16:1ω7 7.73e-01 12 60 28 4.07e-01 0 31 69
C18:0 1.35e-01 34 5 60 7.75e-02 9 1 90
C18:1ω9 2.86e-01 53 11 36 2.3e-01 0 0 100
C18:1ω7 2.22e-01 43 4 53 1.97e-01 0 15 84
C18:2ω6 2.91e-01 55 7 38 2.11e-01 0 5 95
C18:3ω3 6.62e-01 13 67 19 3.74e-01 0 23 76
C20:1ω9 3.95e-01 37 36 27 3.51e-01 1 23 76
C20:3ω6 1.88e-01 1 1 98 1.28e-01 23 4 73
C20:4ω6 9.94e-02 3 2 95 7.16e-02 11 24 65
C20:5ω3 4.7e-01 0 54 46 1.5e-01 13 4 83
C22:6ω3 2.58e-01 68 11 21 5.15e-01 58 40 2
Total FA 2.12e-01 37 0 63 1.80e-01 3 5 91
Total ω9 b 2.79e-01 51 12 37 2.31e-01 0 1 99
Total ω3 c 2.37e-01 2 52 47 4.01e-01 62 32 5
Total ω6 d 2.75e-01 54 6 39 1.81e-01 0 6 93
C20:5ω3+C22:6ω3 2.48e-01 68 8 25 4.86e-01 58 40 2
C20:3ω6+C20:4ω6 1.04e-01 2 1 97 7.28e-02 13 28 58
Total sat + mono e 1.94e-01 12 10 78 1.91e-01 1 12 87
aMSPE, CE, RE and DE are deﬁned in footnote a of Table 5
bC16:1ω9 + C18:1ω9 + C20:1ω9
cSum of C18:3ω3 , C20:5ω3 , C22:6ω3
dSum of C18:2ω6 , C20:3ω6 , C20:4ω6
esum of saturated (C14:0 + C16:0 + C18:0) and monounsaturated (C16:1ω7, C16:1ω9,
C18:1ω7, C18:1ωP ) fatty acids.
Table 7: MSPE coeﬃcient of variation and its decomposition in the model 3 predicting fatty
acids composition in mouse liver during fasting. This model includes fatty acid inﬂux from
adipose tissue, oxidation of fatty acids and biosynthesis of polyunsaturated fatty acids.
Genotype PPARα knock out mice Wild type mice
Statistics cvMSPEa CE(%) RE(%) DE(%) cvMSPE CE(%) RE(%) DE(%)
C14:0 2.77e-01 0 24 76 3.23e-01 0 12 88
C16:0 3.16e-01 6 57 37 2.47e-01 5 42 53
C16:1ω9 2.52e-01 0 13 87 3.17e-01 3 12 85
C16:1ω7 7.73e-01 12 60 28 4e-01 1 28 71
C18:0 1.35e-01 34 5 60 7.96e-02 13 3 84
C18:1ω9 2.86e-01 53 11 36 2.31e-01 0 1 99
C18:1ω7 2.22e-01 43 4 53 1.93e-01 2 11 87
C18:2ω6 2.91e-01 55 7 38 2.09e-01 1 3 96
C18:3ω3 4.41e-01 0 56 44 5.08e-01 56 1 44
C20:1ω9 3.95e-01 37 36 27 3.57e-01 1 26 74
C20:3ω6 1.88e-01 1 1 98 1.30e-01 28 3 69
C20:4ω6 9.94e-02 3 2 95 7.25e-02 6 30 64
C20:5ω3 4.7e-01 0 54 46 1.5e-01 13 4 83
C22:6ω3 1.40e-01 14 16 70 1.19e-01 51 20 29
Total FA 2.12e-01 37 0 63 1.80e-01 3 5 91
Total ω9 b 2.79e-01 51 12 37 2.33e-01 0 2 98
Total ω3 c 2.37e-01 2 52 47 1.68e-01 60 8 33
Total ω6 d 2.75e-01 54 6 39 1.8e-01 1 4 95
C20:5ω3+C22:6ω3 1.50e-01 12 20 68 1.17e-01 51 17 32
C20:3ω6+C20:4ω6 1.04e-01 2 1 97 7.34e-02 9 33 57
Total sat + mono e 1.94e-01 12 10 78 1.89e-01 3 9 89
aMSPE, CE, RE and DE are deﬁned in footnote a of Table 5
bC16:1ω9 + C18:1ω9 + C20:1ω9
cSum of C18:3ω3 , C20:5ω3 , C22:6ω3
dSum of C18:2ω6 , C20:3ω6 , C20:4ω6
esum of saturated (C14:0 + C16:0 + C18:0) and monounsaturated (C16:1ω7, C16:1ω9,
C18:1ω7, C18:1ωP ) fatty acids.
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Figure 1: Pathways that inﬂuence fatty acid compositon in the liver. The main path-
ways inﬂuencing hepatic fatty acid quantities are indicated by streight arrows. Acetyl-
Coenzyme A (AcoA) and malonyl-Coenzyme A (MalonylCoA) are pivots in hepatic intermedi-
ary metabolism. Transcriptional regulators of fatty acid synthesis, oxidation or desaturation
are the sterol regulatory element binding transcription factor 1 (SREBP1) and peroxisome
proliferator-activated receptor alpha (PPARα). (+) signs for an activation, whereas (-) signs
for an inhibition of the pathway. During fasting, the pathways with a white cross are assumed
to be inactive, and regulations marked with a black cross are assumed to have no direct
inﬂuence on variations of fatty acid composition in the liver.
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Figure 2: Transformations between fatty acids. Fatty acids are separated in 3 classes : satu-
rated and monunsaturated, ω6, and ω3. The enzymes regulating desaturation and elongation
are shown as delta-5-desaurase (D5D), delta-6-desaurase (D6D) and delta-9 desaurase (D9D).
Reactions of interconvertion than occur only between fatty acids of a same class are repre-
sented by a solid line. The reactions allowing complete oxidation, importation, or synthesis
of fatty acids from glucose are not shown.
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Figure 3: Models built for wild-type and PPARα knockout (KO) mice according to a step-by-
step procedure detailed in section 2.3. Model 1 included only fatty acides (FA) uptake from
adiposite tissues (AT) to liver. Model 2 included both FA uptake and FA oxidation (oxi.) in
liver. Model 3 was similar to model 2 but also included elongation and desaturation (elong.
des.) of FA.
 

 
	

 

 
	

	


	

	

 

 
	



 

 
	

 

 
	

	


	

	

 

 
	


	
	

	
 
	



 

 
	

 

 
	

	


	

	

 

 
	



	

	
 
	



 
 
 
 
	

	

	

	

26
Ac
ce
pte
d m
an
us
cri
pt 
Figure 4: Measured mRNA of delta 6 deaturase in wild-type and PPARα knockout mice liver
during a 72 h fasting. The QPCR data were normalized by TATA-box binding protein (TBP)
expression levels. a indicates a signiﬁcant diﬀerence (Student test, p < 0.05) between the two
genotypes at each time point and b indicates a signiﬁcant diﬀerence (Student test, p < 0.05)
since the onset of fasting. Error bars indicate the standard error of the mean.
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Figure 5: Predicted and observed quantities of fatty acids in the liver of wild type or PPARα
knockout (KO) mice during fasting.
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